Matt Leivo advises clients in a wide variety of transactions, many of them international, with ongoing representation of public and private technology, life sciences, healthcare and consumer-related companies, as well as private equity, venture capital and debt funds, in matters including mergers and acquisitions, public securities offerings, private equity and venture capital, corporate venture capital, joint ventures and debt finance. He also routinely advises clients on corporate governance, exchange listing requirements, '33 Act and '34 Act reporting, global expansion strategies and related issues, including employment, intellectual property and tax matters. In 2007 and 2008, Matt worked in DLA Piper's London office, where he advised companies on cross-border mergers and acquisitions and securities offerings.